GlassScriptPhysician profile
Shannon R Wesley
NPI 1225320526
$821.61
in general payments reported to CMS, 2019-2025
14 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $53.32 · 2021: $147 · 2022: $159 · 2023: $52.00 · 2024: $45.31 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $412.64 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $82.17 | 2023-2024 | |
| Ethicon US, LLC | $65.03 | 2025 | Harmonic, Echelon Circular, Proximate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.60 | 2019 | |
| Atricure, INC. | $44.00 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Ferring Pharmaceuticals INC. | $33.04 | 2019 | |
| Allergan, INC. | $26.57 | 2019 | |
| Olympus America INC. | $22.55 | 2025 | Evis Exera III Colonovideoscope, Endoclot Phs |
| Avanos Medical | $18.11 | 2019 | |
| Solventum Corporation | $17.95 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Thd America, INC. | $15.14 | 2024 | |
| Convatec INC. | $13.80 | 2025 | |
| Medtronic USA, INC. | $11.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Wesley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.